Neuroimaging of Escitalopram in Autism Spectrum Disorder
At a glance
Conditions
NCT06826326
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Hoglund Biomedical Imaging Center
Kansas City, Kansasno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Kathryn E Unruh, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Rewarded Antisaccade taskAt Visit 2 (1 day to 1 month after Screening/Visit 1) and Visit 3 (5 days to 3 weeks after Visit 2)
During the rewarded antisaccade task (R-ANTI), participants are instructed to look away from a peripheral target and to the mirror location in the opposite hemifield (antisaccade) and avoid looking toward the peripheral target (prosaccade). Two trial types are presented: reward and no-reward. Number of prosaccades is compared between reward and no-reward trial types.